RNU6-111P

Across TCGA pan-cancer cohorts, RNU6-111P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU6-111P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-111P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RNU6-111P expression acts as an unfavorable survival marker, although some lineages such as STAD and PAAD show a favorable association.

STAD, READ, and LUSC are the cancer types where RNU6-111P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	III,IV	0.681	0.310	.012	96	view →
READ	OS	Tertile	All	0.166	0.830	<.001	90	view →
LUSC	DFS	Tertile	III,IV	0.010	0.754	<.001	54	view →
PAAD	DFS	Tertile	All	0.854	0.252	.004	36	view →
BLCA	OS	Tertile	IV	0.214	0.602	.014	18	view →
UCS	DFS	Tertile	All	0.136	0.523	.034	18	view →
LAML	DFS	Tertile	All	0.028	0.572	<.001	18	view →
TGCT	DFS	Tertile	All	0.035	0.837	<.001	18	view →
KIRC	OS	Tertile	II,III,IV	0.238	0.540	.012	15	view →
KIRP	OS	Tertile	All	0.756	0.948	.042	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU6-111P–STAD (DFS)

Open the STAD breakdown →